Anti-DKC1/Dyskerin antibody [EPR10399]
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(9 Publications)
Rabbit Recombinant Monoclonal DKC1/Dyskerin antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 9 publications.
View Alternative Names
NOLA4, DKC1, H/ACA ribonucleoprotein complex subunit DKC1, CBF5 homolog, Dyskerin, Nopp140-associated protein of 57 kDa, Nucleolar protein NAP57, Nucleolar protein family A member 4, snoRNP protein DKC1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DKC1/Dyskerin antibody [EPR10399] (AB156877)
Immunohistochemical analysis of paraffin embedded Human melanoma tissue labeling DKC1/Dyskerin with ab156877 antibody at a dilution of 1/50.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-DKC1/Dyskerin antibody [EPR10399] (AB156877)
Immunofluorescence analysis of HeLa cells labeling DKC1/Dyskerin with ab156877 antibody at a dilution of 1/100.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DKC1/Dyskerin antibody [EPR10399] (AB156877)
Immunohistochemical analysis of paraffin embedded Human placenta tissue labeling DKC1/Dyskerin with ab156877 antibody at a dilution of 1/50.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-DKC1/Dyskerin antibody [EPR10399] (AB156877)
All lanes:
Western blot - Anti-DKC1/Dyskerin antibody [EPR10399] (ab156877) at 1/1000 dilution
Lane 1:
SW480 cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
MCF-7 cell lysate at 10 µg
Predicted band size: 58 kDa
true
Related conjugates and formulations (1)
-
Anti-DKC1/Dyskerin antibody [EPR10399] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Dyskerin is essential for maintaining the integrity of ribosomal RNA through its action within the H/ACA ribonucleoprotein complex. The protein binds H/ACA box small nucleolar RNAs (snoRNAs) which guides it to specific uridine residues in rRNA thereby modifying them to pseudouridine. These modifications have an important role in forming functional ribosomes. Additionally Dyskerin contributes to the stabilization of telomerase RNA component which impacts telomere maintenance and length regulation.
Pathways
The role of Dyskerin in ribosome biogenesis directly connects it to cellular growth and protein synthesis pathways. It associates with NOP10 GAR1 and NHP2 in the H/ACA ribonucleoprotein complex contributing to the processing of precursor rRNA. Dyskerin also associates with telomerase complex proteins like TERT functioning in the telomere maintenance pathway. In these pathways its activity ensures the accurate synthesis of proteins and the preservation of genomic stability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:5728 PubMed39962164
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 30:144 PubMed39256642
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:2425 PubMed38499544
2024
Applications
Unspecified application
Species
Unspecified reactive species
Human molecular genetics 32:2901-2912 PubMed37440454
2023
Applications
Unspecified application
Species
Unspecified reactive species
World journal of surgical oncology 21:111 PubMed36973749
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:727595 PubMed35118063
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 20:2183-2190 PubMed32782535
2020
Applications
Unspecified application
Species
Unspecified reactive species
FEBS letters 594:175-188 PubMed31365120
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of enzyme inhibition and medicinal chemistry 33:1199-1211 PubMed30132373
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com